Since TrumpRx was announced in 2025, 16 Big Pharma companies have agreed to sell their drugs via the platform, including ...

Within the context of “The Great Repricing,” this distinction matters. The pressure on the commercial channel is not coming ...

What 2025 means for the life sciences sector in the New Year. If I had to describe 2025 in one phrase, it would be this: a year of two halves, held together by uncertainty.

In reality, program design covers everything from offer amount and caps to eligibility rules and channel mix, yet many ...

In today’s Pharma Pulse, the FTC secures a multi-billion-dollar settlement against the "rebate trap," while Congress provides ...

This year brings several major healthcare policy changes for patients. While some of these changes improve healthcare access and affordability, two key decisions could have a detrimental impact on ...